MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 100 filers reported holding MEIRAGTX HLDGS PLC in Q4 2021. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,357 | -42.4% | 12,700 | -21.1% | 0.00% | – |
Q2 2023 | $108,192 | +30.0% | 16,100 | 0.0% | 0.00% | – |
Q1 2023 | $83,237 | -77.0% | 16,100 | -71.0% | 0.00% | -100.0% |
Q4 2022 | $362,153 | +8.4% | 55,545 | +25.9% | 0.00% | 0.0% |
Q2 2022 | $334,000 | -66.4% | 44,131 | -38.5% | 0.00% | -66.7% |
Q1 2022 | $994,000 | -52.5% | 71,791 | -18.5% | 0.00% | -25.0% |
Q4 2021 | $2,091,000 | +252.0% | 88,073 | +124.5% | 0.00% | +100.0% |
Q4 2020 | $594,000 | -54.3% | 39,224 | -39.6% | 0.00% | -50.0% |
Q4 2019 | $1,300,000 | -12.5% | 64,931 | -30.3% | 0.00% | -20.0% |
Q3 2019 | $1,485,000 | – | 93,096 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
PA Capital LLC | 39,039 | $525,000 | 0.46% |